Skip to content
Homepage
Author:
Tarsus Pharmaceuticals, Inc
Posted Date:
July 13, 2026
Tarsus Pharmaceuticals Announces Executive Leadership Transition as Company Advances Next Phase of Growth
Tarsus Pharmaceuticals, Inc
July 13, 2026
Tarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix Medical and Late-Stage Asset IRX-101
Tarsus Pharmaceuticals, Inc
July 8, 2026
